
| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | State Street Navigator Securities Lending Portfolio II | — | 8.0095% |
| 2 | Apellis Pharmaceuticals Inc | — | 1.8347% |
| 3 | Alkermes PLC | — | 1.4510% |
| 4 | Madrigal Pharmaceuticals Inc | — | 1.3829% |
| 5 | TG Therapeutics Inc |
Last synced Jun 10, 2026, 12:33 AM · Price and AUM from Yahoo Finance · Holdings from SEC N-PORT filings
| — |
| 1.3496% |
| 6 | Insmed Inc | — | 1.3369% |
| 7 | Scholar Rock Holding Corp | — | 1.2973% |
| 8 | Apogee Therapeutics Inc | — | 1.2843% |
| 9 | Protagonist Therapeutics Inc | — | 1.2449% |
| 10 | Summit Therapeutics Inc | — | 1.2411% |
| 11 | United Therapeutics Corp | — | 1.2405% |
| 12 | Praxis Precision Medicines Inc | — | 1.2362% |
| 13 | Arrowhead Pharmaceuticals Inc | — | 1.2298% |
| 14 | Cogent Biosciences Inc | — | 1.2157% |
| 15 | Bridgebio Pharma Inc | — | 1.1855% |
| 16 | PTC Therapeutics Inc | — | 1.1822% |
| 17 | Cytokinetics Inc | — | 1.1804% |
| 18 | Alnylam Pharmaceuticals Inc | — | 1.1767% |
| 19 | Exelixis Inc | — | 1.1707% |
| 20 | Nuvalent Inc | — | 1.1669% |
| 21 | Kymera Therapeutics Inc | — | 1.1643% |
| 22 | CG oncology Inc | — | 1.1625% |
| 23 | Natera Inc | — | 1.1592% |
| 24 | Neurocrine Biosciences Inc | — | 1.1590% |
| 25 | Twist Bioscience Corp | — | 1.1557% |
| 26 | Krystal Biotech Inc | — | 1.1545% |
| 27 | Vaxcyte Inc | — | 1.1511% |
| 28 | Mirum Pharmaceuticals Inc | — | 1.1475% |
| 29 | Amicus Therapeutics Inc | — | 1.1467% |
| 30 | Ionis Pharmaceuticals Inc | — | 1.1443% |
| 31 | Travere Therapeutics Inc | — | 1.1442% |
| 32 | Arcellx Inc | — | 1.1441% |
| 33 | Regeneron Pharmaceuticals Inc | — | 1.1370% |
| 34 | Incyte Corp | — | 1.1331% |
| 35 | Celcuity Inc | — | 1.1237% |
| 36 | Revolution Medicines Inc | — | 1.1129% |
| 37 | Halozyme Therapeutics Inc | — | 1.1080% |
| 38 | Rhythm Pharmaceuticals Inc | — | 1.1010% |
| 39 | Biogen Inc | — | 1.0970% |
| 40 | Arcutis Biotherapeutics Inc | — | 1.0895% |
| 41 | AbbVie Inc | — | 1.0886% |
| 42 | Gilead Sciences Inc | — | 1.0878% |
| 43 | CRISPR Therapeutics AG | — | 1.0857% |
| 44 | BioMarin Pharmaceutical Inc | — | 1.0673% |
| 45 | Roivant Sciences Ltd | — | 1.0672% |
| 46 | Amgen Inc | — | 1.0627% |
| 47 | ImmunityBio Inc | — | 1.0569% |
| 48 | Beam Therapeutics Inc | — | 1.0413% |
| 49 | Viking Therapeutics Inc | — | 1.0370% |
| 50 | Vera Therapeutics Inc | — | 1.0347% |